Skip to content

Author

Shu-Lin Luo

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Calsyntenin-2 promotes the pathology of acute myeloid leukemia via activation of the JAK2-STAT3 signaling pathway.

PURPOSE Although considerable progress has been made in the treatment of acute myeloid leukemia (AML), therapeutic outcomes remain unsatisfactory. Thus, it is of great important to investigate the leukemiagenesis mechanism of AML. Previous studies indicated that Calsyntenin-2 (CLSTN2) was closely associated with the pr...

Yu-Ting Dou, Xu Cao, Ke Ji et al. · 0 citations
Sep 2026

CAPN1 promotes the progression of MLL-rearranged acute myeloid leukemia by suppressing SHP-1 and activating MAPK/ERK signaling pathway.

BACKGROUND The MLL-rearranged (MLL-r) acute myeloid leukemia (AML) represents a hematological malignancy with a dismal prognosis and a pressing demand for innovative therapeutic targets. CAPN1 is overexpressed in MLL-r AML and predicts poor prognosis, however, its roles in MLL-r AML remains unclear. METHODS Prognosti...

Jia-Yi Liu, Xu Cao, Yan Lu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.